CHICAGO & MIAMI--(BUSINESS WIRE)--The Alpha-1 Foundation and the Foundation for Sarcoidosis Research today praised the National Heart, Lung and Blood Institute of the National Institutes of Health for a planned three-year study of two serious conditions that affect the lungs: Alpha-1 Antitrypsin Deficiency (Alpha-1) and sarcoidosis.